Tech Company Financing Transactions
Nanite Funding Round
Nanite, based in Boston, secured $2 million in funding from Cystic Fibrosis Foundation.
Transaction Overview
Company Name
Announced On
3/15/2023
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Investors
Cystic Fibrosis Foundation (Lead Investor)
Proceeds Purpose
The company intends to use the funds for the development of a gene delivery technologies for the lung.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
6 Liberty Square 6128
Boston, MA 02109
USA
Boston, MA 02109
USA
Phone
Undisclosed
Website
Email Address
Overview
Nanite is a next-generation non-viral gene delivery company developing a new class of programmable polymer nanoparticles for a range of modalities and indications. The company's AI-driven platform, SAYER, combines cutting-edge high-throughput experimental and computational methods to design fit-for-purpose delivery vehicles delivering a broad range of genetic cargoes with tissue specificity.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sean Kevlahan
Co-Founder
Shashi Murthy
Co-Founder
Thomas Neenan
Co-Founder
Theresa Reineke
Browse more venture capital transactions:
Prev: 3/15/2023: Monitaur venture capital transaction
Next: 3/15/2023: Fount venture capital transaction
Share this article
Where The Data Comes From
We record every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs